Global Insulin Pump Market Worth $6 Billion by 2028 - Exclusive Market Research Report by Arizton

 New opportunities for the growth of the insulin pump market have been created by the explosion in research, development, and published studies about the closed-loop system with insulin pumps in diabetes management. Several hybrid systems are expected to be commercialized in the future associated with insulin delivery.

CHICAGO, Feb. 16, 2023 /PRNewswire/ -- [279 Pages] According to Arizton's latest research report, the insulin pump market will grow at a CAGR OF 8.4% during 2022-2028. New products launched and technological advancement in diabetes care, increasing demand for closed-loop technology, and transition of patients from multiple daily injections to the insulin pump are key trends in the market.

Advances in insulin delivery for diabetic patients are highly accepted worldwide, giving a new direction to diabetes management. Over the last decades, several improvements have been registered in the insulin pump market enhancing diabetes management and driving market growth. The explosion in R&D and published studies about the closed-loop system in diabetes management gives new market growth opportunities. Several hybrid systems are expected to be commercialized in insulin delivery solutions. Moreover, advanced closed-loop systems combine a predictive algorithm with user control. These systems develop advanced features such as a predictive algorithm that allows accounting CGM values and insulin on board (IOB), consideration of user's settings, and carbohydrates that help them automatically adjust the insulin delivery.

INSULIN PUMP MARKET REPORT SCOPE

INSULIN PUMP MARKET DYNAMICS

Drivers

• Increase in the Prevalence of Diabetes & Expenditure
• Government Initiatives for Diabetes Care Management
• Available Reimbursement Policies and Healthcare Insurance for Insulin Pumps

Restraints

• High-cost Burden of Insulin Pumps.
• Available Alternative Solutions for Insulin Pumps.
• Increase in Undiagnosed Diabetic Population.

Opportunities

• New Product Launches and Technological Advances in Diabetes Care.
• Increase in Demand for Closed loop Technology.
• The transition of Patients from Multiple Daily Injections to Insulin Pumps.

Click Here to Download the Free Sample Report 

F-Halfmann la Roche has a Diabetes Care Middle East unit in the UAE. It is one of the leading market players operating in the region, offering advanced insulin pump systems. The company has achieved strong market penetration in a short period. The company offers an Accu-Check Combo insulin pump and Accu-Check Solo Tubeless Patch Pump. With prioritizing patient needs, the company continuously invests in clinical studies and trials to ensure that evidence trials are established. Moreover, one of the leading insulin pump market companies, Medtronic, plays a vital role in Middle East Africa, offering comprehensive ranges of insulin pump systems. In 2022, Insulet Corporation, one of the leading companies, started offering tubeless insulin pump technology with its brand Omnipod insulin pump system and is celebrating representation and inclusion for the diabetes communities through activation in the most popular Nintendo video game animal crossing.

APAC TO WITNESS FASTEST GROWTH RATE IN THE INSULIN PUMP MARKET

APAC is a rapidly growing market for insulin pumps with a significant volume of the diabetic patient population and rising diabetes health expenditure. China is one of the dominating countries for insulin pumps, with the high expenditure and highest diabetic patient population across the world. In addition, the access and continuous development of insulin pump delivery devices increase awareness among the people. The available market players, R&D, product launches, and upgradation in the country accelerate the availability of insulin pumps. Moreover, in Japan, the rising type 1 diabetic patient population with high demand for safer insulin delivery solutions propels the market growth. In addition, market players, such as Terumo Corporation, are stepping up for insulin pump delivery in the regional and global markets, thereby giving new shape to the market landscape in the country.

WHY SHOULD YOU BUY THIS RESEARCH REPORT?

• Market Revenue 2022–2028
• Market Segmentation Analysis
• Latest and innovative technologies.
• COVID-19 impact analysis of the industry.
• Company profiles of major and other prominent vendors.
• Industry shares of major vendors.

Click Here to Download the Free Sample Report 

KEY COMPANY PROFILES

• Insulet Corporation
• Medtronic
• Tandem Diabetes Care
• CeQur Simplicity
• EOFLOW
• Debiotech SA
• F-Hoffmann-La Roche
• Medzer.com
• MicroPort Scientific
• Novo Nordisk A/S
• SOOIL Developments Co., Ltd.
• Terumo
• ViCentra B.V.
• Ypsomed
• Mannkind

MARKET SEGMENTATION

Products

• Pump
• Tethered Pump
• Patch Pump
• Consumables

Disease

• Type 1 Diabetes
• Type 2 Diabetes

End-Users

• Hospital
• Home Healthcare Settings
• Others

Geography

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• APAC
• China
• Japan
• India
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• South Africa

CHECK OUT SOME OF THE TOP-SELLING RESEARCH RELATED REPORTS:

Insulin Pens Market -  The insulin pens market is growing with a CAGR of 6.26% from 2021-2027 and is expected to reach USD 1.56 billion by 2027. The high prevalence of diabetes across various healthcare settings and the subsequent rise in demand for insulin pens to manage diabetes have majorly contributed to the market growth in recent years. The global insulin pen market is also growing due to rising awareness among healthcare professionals and patients regarding insulin pen usage to manage diabetes better.

Blood Glucose Test Strips Market -  The global blood glucose test strips market was valued at USD 9 billion in 2020 and is projected to reach USD 13 billion in 2026. The global market is one of the diagnostics market's major segments and is growing steadily during the forecast period. The surge in market growth can be attributed to the increasing prevalence/incidence of diabetes worldwide. However, the outbreak of the COVID-19 pandemic has immensely contributed to the market's growth.

Blood Glucose Monitoring Consumables Market -  The global blood glucose monitoring consumables market size was valued at USD 14.14 billion to reach USD 29 billion by 2026. The market has witnessed significant growth due to the growing prevalence of diabetes and the increasing awareness of self-management of diabetes.

Blood Glucose Monitoring Devices Market -  The global blood glucose monitoring devices market will reach over USD 37 billion by 2026. The diabetes monitoring industry is growing steadily because of the increasing prevalence of diabetes and the rise in chronic diseases. Globally, the incidence of diabetes has been increasing at an alarming rate due to changing lifestyles, growing alcohol consumption, and an increasing number of smokers. In emerging markets and newly industrializing countries, the number of new diabetes cases is expected to significantly grow in the coming years.

TABLE OF CONTENT

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY PRODUCT

4.3.2 MARKET SEGMENTATION BY PATIENT GROUP

4.3.3 MARKET SEGMENTATION BY END-USER

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

6.1 OVERVIEW

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

9.1 NEW PRODUCT LAUNCHES AND TECHNOLOGICAL ADVANCES IN DIABETES CARE

9.2 INCREASE IN DEMAND FOR CLOSED-LOOP TECHNOLOGY

9.3 TRANSITION OF PATIENTS FROM MULTIPLE DAILY INJECTIONS TO INSULIN PUMPS

10 MARKET GROWTH ENABLERS

10.1 INCREASE IN PREVALENCE OF DIABETES & EXPENDITURE

10.2 GOVERNMENT INITIATIVES FOR DIABETES CARE MANAGEMENT

10.3 AVAILABLE REIMBURSEMENT POLICIES AND HEALTHCARE INSURANCE FOR INSULIN PUMPS

11 MARKET RESTRAINTS

11.1 HIGH-COST BURDEN OF INSULIN PUMPS

11.2 AVAILABLE ALTERNATIVE SOLUTIONS FOR INSULIN PUMPS

11.3 INCREASE IN UNDIAGNOSED DIABETIC POPULATION

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 INSIGHTS BY PATIENT GROUP

12.2.2 INSIGHTS BY PRODUCT

12.2.3 INSIGHTS BY END-USER

12.2.4 INSIGHTS BY GEOGRAPHY

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 PUMP

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 TETHERED PUMP

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

13.5 PATCH PUMP

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 MARKET BY GEOGRAPHY

13.6 CONSUMABLES

13.6.1 MARKET OVERVIEW

13.6.2 MARKET SIZE & FORECAST

13.6.3 MARKET BY GEOGRAPHY

14 PATIENT GROUP

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 TYPE 1 DIABETES

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 TYPE 2 DIABETES

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

15 END-USER

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 HOSPITALS

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 HOME HEALTHCARE SETTINGS

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

15.5 OTHERS

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.5.3 MARKET BY GEOGRAPHY

16 GEOGRAPHY

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.3 PRODUCT

17.3.1 MARKET SIZE & FORECAST

17.4 PUMP

17.4.1 MARKET SIZE & FORECAST

17.5 PATIENT GROUP

17.5.1 MARKET SIZE & FORECAST

17.6 END-USER

17.6.1 MARKET SIZE & FORECAST

17.7 KEY COUNTRIES

17.7.1 US: MARKET SIZE & FORECAST

17.7.2 CANADA: MARKET SIZE & FORECAST

18 EUROPE

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 PRODUCT

18.3.1 MARKET SIZE & FORECAST

18.4 PUMP

18.4.1 MARKET SIZE & FORECAST

18.5 PATIENT GROUP

18.5.1 MARKET SIZE & FORECAST

18.6 END-USER

18.6.1 MARKET SIZE & FORECAST

18.7 KEY COUNTRIES

18.7.1 GERMANY: MARKET SIZE & FORECAST

18.7.2 FRANCE: MARKET SIZE & FORECAST

18.7.3 UK: MARKET SIZE & FORECAST

18.7.4 ITALY: MARKET SIZE & FORECAST

18.7.5 SPAIN: MARKET SIZE & FORECAST

19 APAC

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 PRODUCT

19.3.1 MARKET SIZE & FORECAST

19.4 PUMP

19.4.1 MARKET SIZE & FORECAST

19.5 PATIENT GROUP

19.5.1 MARKET SIZE & FORECAST

19.6 END-USER

19.6.1 MARKET SIZE & FORECAST

19.7 KEY COUNTRIES

19.7.1 CHINA: MARKET SIZE & FORECAST

19.7.2 JAPAN: MARKET SIZE & FORECAST

19.7.3 INDIA: MARKET SIZE & FORECAST

19.7.4 SOUTH KOREA: MARKET SIZE & FORECAST

19.7.5 AUSTRALIA: MARKET SIZE & FORECAST

20 LATIN AMERICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 PRODUCT

20.3.1 MARKET SIZE & FORECAST

20.4 PUMP

20.4.1 MARKET SIZE & FORECAST

20.5 PATIENT GROUP

20.5.1 MARKET SIZE & FORECAST

20.6 END-USER

20.6.1 MARKET SIZE & FORECAST

20.7 KEY COUNTRIES

20.7.1 BRAZIL: MARKET SIZE & FORECAST

20.7.2 MEXICO: MARKET SIZE & FORECAST

20.7.3 ARGENTINA: MARKET SIZE & FORECAST

21 MIDDLE EAST & AFRICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 PRODUCT

21.3.1 MARKET SIZE & FORECAST

21.4 PUMP

21.4.1 MARKET SIZE & FORECAST

21.5 PATIENT GROUP

21.5.1 MARKET SIZE & FORECAST

21.6 END-USER

21.6.1 MARKET SIZE & FORECAST

21.7 KEY COUNTRIES

21.7.1 TURKEY: MARKET SIZE & FORECAST

21.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST

21.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

22.1 COMPETITION OVERVIEW

22.2 MARKET SHARE ANALYSIS

22.2.1 INSULET CORPORATION

22.2.2 MEDTRONIC

22.2.3 TANDEM DIABETES CARE

23 KEY COMPANY PROFILES

23.1 INSULET CORPORATION

23.1.1 BUSINESS OVERVIEW

23.1.2 PRODUCT OFFERINGS

23.1.3 KEY STRATEGIES

23.1.4 KEY STRENGTHS

23.1.5 KEY OPPORTUNITIES

23.2 MEDTRONIC

23.3 TANDEM DIABETES CARE

24 OTHER PROMINENT VENDORS

24.1 CEQUR SIMPLICITY

24.1.1 BUSINESS OVERVIEW

24.1.2 PRODUCT OFFERINGS

24.2 EOFLOW

24.3 DEBIOTECH SA

24.4 F-HOFFMANN-LA ROCHE

24.5 MEDZER.COM

24.6 MICROPORT SCIENTIFIC

24.7 NOVO NORDISK A/S

24.8 SOOIL DEVELOPMENTS CO., LTD.

24.9 TERUMO

24.10 VICENTRA B. V.

24.11 YPSOMED

24.12 MANNKIND

25 REPORT SUMMARY

25.1 KEY TAKEAWAYS

25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

26.1 MARKET BY GEOGRAPHY

26.2 MARKET BY PRODUCT

26.3 MARKET BY PATIENT GROUP

26.4 MARKET BY END-USER

26.5 PRODUCT: MARKET BY GEOGRAPHY

26.5.1 PUMP: MARKET BY GEOGRAPHY

26.5.2 CONSUMABLES: MARKET BY GEOGRAPHY

26.5.3 TETHERED PUMP: MARKET BY GEOGRAPHY

26.5.4 PATCH PUMP: MARKET BY GEOGRAPHY

26.6 PATIENT GROUP: MARKET BY GEOGRAPHY

26.6.1 TYPE 1 DIABETES: MARKET BY GEOGRAPHY

26.6.2 TYPE 2 DIABETES: MARKET BY GEOGRAPHY

26.7 END-USER: MARKET BY GEOGRAPHY

26.7.1 HOSPITALS: MARKET BY GEOGRAPHY

26.7.2 HOME HEALTHCARE SETTINGS: MARKET BY GEOGRAPHY

26.7.3 OTHERS: MARKET BY GEOGRAPHY

27 APPENDIX

27.1 ABBREVIATIONS

About Us:   

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.  

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.  

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.  

Click Here to Contact Us 
Call: +1-312-235-2040
         +1 302 469 0707
Mail: [email protected]

Photo: https://mma.prnewswire.com/media/2003966/INSULIN_PUMP_MARKET.jpg
Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg

SOURCE Arizton Advisory & Intelligence